Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
Product StageCustomersPartnersManagement Changes
Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
Product StageFDA approved/pending approval
Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
FDA approved/pending approval
ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
Else Nutrition Holdings Inc (BABYF) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
CustomersLayoffsFDA approved/pending approval
Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
Product StageCustomersExpandLayoffs
Else Nutrition CEO Highlights Urgent Need for Infant Formula Alternatives in The Washington Times Op-Ed
Product StageFDA approved/pending approval
Else Nutrition Expands Nationwide with Kids Ready-to-Drink Shakes in 1,000 Leading U.S. Retailer Stores
CustomersProduct Stage
ELSE NUTRITION PROVIDES BI-WEEKLY DEFAULT STATUS REPORT
ELSE NUTRITION PROVIDES BI-WEEKLY DEFAULT STATUS REPORT
Else Nutrition Launches 'Formula for Change' Campaign, Building on Momentum from Operation Stork Speed to Deliver Real Choice for American Families
Product Stage
ELSE NUTRITION PROVIDES BI-WEEKLY DEFAULT STATUS REPORT
ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER
Management Changes
Else Nutrition Reschedules 2024 Fiscal Year Business Update Conference Call
Else Nutrition Schedules 2024 Fiscal Year Business Update Conference Call
Product Stage
Else Nutrition Commends HHS & FDA's Operation Stork Speed on Expanding Infant Formula Options
Product StageFDA approved/pending approval
Else Nutrition Closes US$300,000 Private Placement
Investment
+ 143 more articles